Thursday, 25 March 2021

Aussie biotech Starpharma signs deal to sell COVID nose spray in Britain

The Melbourne-based firm’s market value is approaching the billion-dollar mark amid rising investor interest in its COVID-preventative treatment.

from Sydney Morning Herald - Latest News https://ift.tt/3w0q4PF
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)